New use of semaglutide injection

DRUG2 trials

Sponsors

Brigham and Women's Hospital

Conditions

Diabetes Mellitus, Type 2

Unknown Phase

Prediction of the SEPRA Diabetes Trial in Healthcare Claims Data

CompletedNCT05577728

Brigham and Women's HospitalDiabetes Mellitus, Type 2

Start: 2021-07-01End: 2022-10-31Updated: 2024-09-25

Emulation of the SUSTAIN6 Diabetes Trial Using Healthcare Claims

CompletedNCT06659744

Brigham and Women's HospitalDiabetes Mellitus, Type 2

Start: 2024-10-24End: 2025-03-06Updated: 2025-10-15

Related Papers

Cardiovascular outcomes of semaglutide and tirzepatide for patients with type 2 diabetes in clinical practice.

2025-11-091 citations

Using real-world data to predict findings of an ongoing phase IV trial: glycemic control of semaglutide versus standard of care.

2025-10-29